It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Osteoarthritis Randomized Treatment Study

Clinical Trial Title: 
Randomized Clinical Trial for Knee Osteoarthritis – PRP (Platelet-Rich Plasma) vs. Hyaluronic Acid Intra-articular Injections
Clinical Trial Protocol ID: 
10012103
Clinical Trial Investigator Name: 
Brian Cole, MD
Clinical Trial Protocol Description: 

If a patient meets inclusion criteria, he or she will be randomized to either the PRP or the hyaluronic acid treatment group. Patients receive three total injections total over a course of three weeks. They will have three additional office visits after they have received all injections and will participate in the study for a total of six months. Overall, patients are required to complete six office visits over a course of six months. This is a blinded study, and the identity of the injection given will not be revealed until the last study office visit.

Clinical Trial Eligibility Criteria: 

You may be eligible to participate in this study if you:

  • Experiencing knee pain
  • Have not had surgery within the past six months
  • Must have medical insurance

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.

Clinical Trial Area: 
Orthopedic Conditions
Contact Email: 
Contact Phone: 
(312) 432-2380
Contact Name: 
Kristen Hussey